Home › Why Did Merck Spend $4 Billion on a Tiny Biotech Firm?
 

Keywords :   


Why Did Merck Spend $4 Billion on a Tiny Biotech Firm?

2014-06-14 11:42:27| Biotech - Topix.net

Merck & Co. Inc. has had its sights set on conquering the hepatitis C market for a long time now, and the recovering drugmaker is hoping that a small Cambridge, Massachusetts-based biotech company, Idenix Pharmaceuticals, Inc. , can help it move forward in the race to develop a serious competitor to Gilead Sciences' blockbuster treatment, Sovaldi.

Tags: firm spend billion tiny

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
04.10Summary for Hurricane Kirk (AT2/AL122024)
04.10Tropical Storm Leslie Public Advisory Number 10
More »